(firstQuint)Autoinjector Device Assessment Study.

 Phase I multi-cohort study will employ a flexible study design to accommodate multiple cohorts.

 Healthy male or female subjects >or= 18 years with no significant health issues will be included.

 Each cohort will employ an open-label, single-arm, repeat-dose design.

 Injection failure rates will be continually assessed.

 Injection pain will also be assessed.

.

 Autoinjector Device Assessment Study@highlight

Phase I study to determine the device-related injection failure rate of the single-use, pre-filled autoinjector.

